Literature DB >> 32540583

Positive conversion of COVID-19 after two consecutive negative RT-PCR results: A role of low-dose CT.

Kum Ju Chae1, Gong Yong Jin2, Chang-Seop Lee3, Heung Bum Lee3, Ju-Hyung Lee4, Keun-Sang Kwon4.   

Abstract

Entities:  

Year:  2020        PMID: 32540583      PMCID: PMC7282766          DOI: 10.1016/j.ejrad.2020.109122

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


× No keyword cloud information.
Dear Editor, We recently reviewed papers on discharged COVID-19 patients with positive RT-PCR re-test [1], and we would like to discuss a role of low-dose CT in discharge decision based on our recent experience regarding the positive conversion of COVID-19 after two consecutive negative RT-PCR results. Since the initial outbreak of coronavirus disease 19 (COVID-19) in December 2019, increasing numbers of patients have recovered and been discharged. Now is the time to turn our attention not only to diagnosis and treatment, but also to prevention of reactivation. In order to discharge patients from the hospital, most guidelines include no fever for more than 3 days, improvement of symptoms, and two consecutive negative real-time polymerase chain reaction (RT-PCR) test results [2]. However, there have been reports of false-negative RT-PCR results or reconfirmed cases after discontinuation of quarantine [3,4], highlighting the need to re-evaluate the guidelines for discharge. Also, Dou et al. [1] recently published an article describes serial CT features in discharged COVID-19 patients with positive RT-PCR re-tests, giving us a lesson that follow-up CT after discharge is essential. Accordingly, we would like to introduce a recent case from our hospital. A 72-year-old woman was diagnosed with COVID-19 using an RT-PCR assay for the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) via naso- and oropharyngeal swab and was admitted to our hospital. At admission (Day 9 from the initial symptom), low-dose chest CT (LDCT) revealed patchy peripheral ground-glass opacities (GGOs) in the right upper lobe. The patient had a high fever (> 38.3°C) for five days after hospitalization, and follow-up LDCT revealed progression of the lung lesions. After treatment, the patient’s fever and respiratory symptoms resolved. After 3 days without symptoms, two consecutive naso- and oropharyngeal swabs were negative for viral RNA, and opacities on chest radiographs were improving. The patient therefore met the criteria for hospital discharge (absence of fever or symptoms and two negative RT-PCR results) established by the Korea Centers for Disease Control and Prevention [5]; however, follow-up LDCT prior to discharge revealed newly developed multifocal GGOs in the lower lobes, which led to cancelation of discharge. After an additional 6 days, repeat naso- and oropharyngeal swab testing showed positive conversion. With continued treatment, the patient was discharged after two consecutive negative RT-PCR results and near complete resolution of her previous pneumonia without new lesions on LDCT (Fig. 1 ).
Fig. 1

Clinical and radiologic courses of a 72-year-old patient with COVID-19 with positive conversion of RT-PCR. The patient’s low-dose chest CT identified newly developed lesions after two consecutive negative PCR results (Day 23, 24), which may have indicated reactivation of the disease. Repetition of the PCR test on Day 30 indicated positive conversion. After continued treatment, both radiologic and PCR results were negative on Days 35 and 36.

The depth of shading in the squares indicates the severity of fever and C-reactive protein concentration as follows: fever was categorized as low-grade fever (37.5–38.2℃), or high-grade fever (> 38.3℃); C-reactive protein elevation was categorized as < 1, 1–4.9, 5–9.9, ≥ 10 mg/dL. Lopinavir/ritonavir and hydroxychloroquine were used as treatments. PCR = polymerase chain reaction.

Clinical and radiologic courses of a 72-year-old patient with COVID-19 with positive conversion of RT-PCR. The patient’s low-dose chest CT identified newly developed lesions after two consecutive negative PCR results (Day 23, 24), which may have indicated reactivation of the disease. Repetition of the PCR test on Day 30 indicated positive conversion. After continued treatment, both radiologic and PCR results were negative on Days 35 and 36. The depth of shading in the squares indicates the severity of fever and C-reactive protein concentration as follows: fever was categorized as low-grade fever (37.5–38.2℃), or high-grade fever (> 38.3℃); C-reactive protein elevation was categorized as < 1, 1–4.9, 5–9.9, ≥ 10 mg/dL. Lopinavir/ritonavir and hydroxychloroquine were used as treatments. PCR = polymerase chain reaction. This case indicates that it is advisable to reconsider discharging patients with COVID-19 pneumonia whose radiologic manifestations and PCR results are mismatched. With regard to recently identified reactivation of COVID-19, use of LDCT as an ancillary diagnostic tool may reduce possible disease spread and improve our understanding of the pathophysiology of conversion of previously negative RT-PCR results to positive after discontinuation of quarantine.

Transparency document

  3 in total

1.  Positive RT-PCR Test Results in Patients Recovered From COVID-19.

Authors:  Lan Lan; Dan Xu; Guangming Ye; Chen Xia; Shaokang Wang; Yirong Li; Haibo Xu
Journal:  JAMA       Date:  2020-04-21       Impact factor: 56.272

2.  Serial CT features in discharged COVID-19 patients with positive RT-PCR re-test.

Authors:  Peipei Dou; Shuai Zhang; Chen Wang; Lulu Cai; Zhongxiao Liu; Qinghong Xu; Xing Li; Yankai Meng; Yutao Rong; Shaodong Li; Chunfeng Hu; Kai Xu
Journal:  Eur J Radiol       Date:  2020-04-18       Impact factor: 3.528

3.  SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients.

Authors:  Huanqin Han; Qingfeng Luo; Fan Mo; Lieming Long; Weiqiang Zheng
Journal:  Lancet Infect Dis       Date:  2020-03-12       Impact factor: 25.071

  3 in total
  5 in total

1.  Culturing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Diagnosis and Genome Sequencing.

Authors:  Zhiqi Zeng; Hua Guo; Liping Chen; Zhengshi Lin; Wenda Guan; Yutao Wang; Haiming Jiang; Xiao Wu; Yong Yin; Zelong Gao; Canxiong Chen; Zifeng Yang
Journal:  Lab Med       Date:  2022-06-17

2.  Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature.

Authors:  Anna Gidari; Marco Nofri; Luca Saccarelli; Sabrina Bastianelli; Samuele Sabbatini; Silvia Bozza; Barbara Camilloni; Igino Fusco-Moffa; Claudia Monari; Edoardo De Robertis; Antonella Mencacci; Daniela Francisci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-10       Impact factor: 3.267

3.  An original deep learning model using limited data for COVID-19 discrimination: A multicenter study.

Authors:  Fangyi Xu; Kaihua Lou; Chao Chen; Qingqing Chen; Dawei Wang; Jiangfen Wu; Wenchao Zhu; Weixiong Tan; Yong Zhou; Yongjiu Liu; Bing Wang; Xiaoguo Zhang; Zhongfa Zhang; Jianjun Zhang; Mingxia Sun; Guohua Zhang; Guojiao Dai; Hongjie Hu
Journal:  Med Phys       Date:  2022-04-18       Impact factor: 4.506

Review 4.  Reinfection or Reactivation of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.

Authors:  Xiujuan Tang; Salihu S Musa; Shi Zhao; Daihai He
Journal:  Front Public Health       Date:  2021-06-11

Review 5.  Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review.

Authors:  Thi Loi Dao; Van Thuan Hoang; Philippe Gautret
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-28       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.